UA76034U - METHOD OF TREATMENT OF ISCHEMIC ATHEROTROMBOTIC Stroke IN A PERSON WITH ABDOMINAL OBESITY - Google Patents

METHOD OF TREATMENT OF ISCHEMIC ATHEROTROMBOTIC Stroke IN A PERSON WITH ABDOMINAL OBESITY

Info

Publication number
UA76034U
UA76034U UAU201205816U UAU201205816U UA76034U UA 76034 U UA76034 U UA 76034U UA U201205816 U UAU201205816 U UA U201205816U UA U201205816 U UAU201205816 U UA U201205816U UA 76034 U UA76034 U UA 76034U
Authority
UA
Ukraine
Prior art keywords
stroke
ischemic
abdominal obesity
treatment
day
Prior art date
Application number
UAU201205816U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Наталия Владимировна Литвиненко
Михаил Юрьевич Дельва
Original Assignee
Наталия Владимировна Литвиненко
Михаил Юрьевич Дельва
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Наталия Владимировна Литвиненко, Михаил Юрьевич Дельва filed Critical Наталия Владимировна Литвиненко
Priority to UAU201205816U priority Critical patent/UA76034U/en
Publication of UA76034U publication Critical patent/UA76034U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Спосіб лікування ішемічного атеротромботичного інсульту в осіб з абдомінальним ожирінням включає визначення індексу маси тіла, індексу "талія/стегно", верифікацію атеротромботичного підтипу ішемічного інсульту згідно критеріїв TOAST, застосування лікарських препаратів. Пацієнтам з абдомінальним ожирінням призначають аторвастатин в дозі 20 мг перорально один раз на добу незалежно від прийому їжі в один і той же час доби з першого дня після інсульту і протягом наступних 12 тижнів.The method of treatment of ischemic atherothrombotic stroke in persons with abdominal obesity includes determination of body mass index, waist / hip index, verification of atherothrombotic subtype of ischemic stroke according to TOAST criteria, the use of drugs. Patients with abdominal obesity are prescribed atorvastatin at a dose of 20 mg orally once a day, regardless of food intake at the same time of day from the first day after the stroke and for the next 12 weeks.

UAU201205816U 2012-05-14 2012-05-14 METHOD OF TREATMENT OF ISCHEMIC ATHEROTROMBOTIC Stroke IN A PERSON WITH ABDOMINAL OBESITY UA76034U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201205816U UA76034U (en) 2012-05-14 2012-05-14 METHOD OF TREATMENT OF ISCHEMIC ATHEROTROMBOTIC Stroke IN A PERSON WITH ABDOMINAL OBESITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201205816U UA76034U (en) 2012-05-14 2012-05-14 METHOD OF TREATMENT OF ISCHEMIC ATHEROTROMBOTIC Stroke IN A PERSON WITH ABDOMINAL OBESITY

Publications (1)

Publication Number Publication Date
UA76034U true UA76034U (en) 2012-12-25

Family

ID=50844407

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201205816U UA76034U (en) 2012-05-14 2012-05-14 METHOD OF TREATMENT OF ISCHEMIC ATHEROTROMBOTIC Stroke IN A PERSON WITH ABDOMINAL OBESITY

Country Status (1)

Country Link
UA (1) UA76034U (en)

Similar Documents

Publication Publication Date Title
CL2015002691A1 (en) Myostatin antagonist in human subjects
CL2014001587A1 (en) Pharmaceutical combination, pharmaceutical composition or pharmaceutical kit comprising a dpp-4 inhibitor and a glp-1 analog; method to treat and / or prevent obesity or overweight to reduce body weight in a human patient.
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
AR124500A2 (en) INCREASED BIOAVAILABILITY OF THE DRUG IN NALTREXONE THERAPY
EA201591679A1 (en) METHOD OF NON-TOXIC TREATMENT OF ABSTINENT, CAUSED BY MEDICINE
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
EA201491334A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS
NZ606768A (en) Pharmaceutical compositions and methods of treatment
IN2012DN06309A (en)
MX347101B (en) Oral vaccine fast-dissolving dosage form using starch.
NZ606765A (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
EA201690964A1 (en) COMPOSITIONS AND METHODS FOR REDUCING SERIOUS ADVERSE CARDIOVASCULAR PHENOMENA
NZ606977A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
BR112015006848A2 (en) pharmaceutical formulation, weight loss induction method, body fat reduction method, food intake reduction method, method for improving glucose homeostasis, and method for preventing an increase in body mass index of a normal, preterm patient. obese, obese or morbidly obese.
MY200278A (en) Methods of improving exercise capacity in fontan patients using udenafil compositions
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
MX2019005309A (en) Anti-bag3 antibodies in combination with inhibitors of immune check-point for therapeutic use.
UA76034U (en) METHOD OF TREATMENT OF ISCHEMIC ATHEROTROMBOTIC Stroke IN A PERSON WITH ABDOMINAL OBESITY
RU2011101076A (en) METHOD OF REHABILITATION OF PATIENTS WITH CHILDREN'S CEREBRAL PARALYSIS
UA101092U (en) Method of prevention of early and late spontaneous abortions at women with destructive treatment cervical intraepitelial neoplasms in medical background
RU2010107310A (en) METHOD FOR PSYCHOLOGICAL CORRECTION OF OVERBODY WEIGHT
UA61499U (en) massage mat
陈建新 Impact of obesity on laparoscopic-assistedradical gastrectomy for gastric cancer
Solman Asymptomatic hypotension: case report
RU2010111058A (en) METHOD FOR INTEGRATED TREATMENT OF INSULIN RESISTANCE